Generic selectors
Exact matches only
Search in title
Search in content
Filter by Categories
Deals
Features
News
Region
Sectors
Size

Exit

Metacon makes Helbio its own
Metacon has acquired all outstanding shares in its existing portfolio company Helbio, which was spun out of University of Patras two decades ago.
UnifyID bands together with Prove
StartX-backed UnifyID has agreed to an acquisition by Prove for an undisclosed amount.
Clarity Informatics clears path to acquisition
Agilio Software has bought Newcastle spinout Clarity Informatics, a healthtech developer founded in 2000.
Bayer makes it two for two
Noria Therapeutics and PSMA Therapeutics have both been acquired by Bayer, which will integrate their respective assets into its own oncology portfolio.
Iksuda seals $47m investment
IP Group sold a $5m stake to incoming shareholder Celltrion as part of a series A round for Iksuda, a spinout of Bath originally called Glythera.
Century Therapeutics submits IPO filing
The oncology therapy developer has filed for an IPO just two years after emerging from stealth to advance Harvard and Stanford research.
Centessa captures $330m in IPO
Centessa, formed earlier this year through a ten-way merger involving multiple spinouts, has completed a listing in the US.
Lodo likes the sound of acquisition
Zymergen has purchased Lodo Therapeutics, which is advancing Rockefeller research, for an undisclosed sum five years after the company raised its only funding round.

Other News

Effector exercises reverse merger
UC San Francisco spinout Effector Therapeutics is set to go public through a reverse merger with Locust Walk Acquisition Corp that includes a $60m PIPE financing.
Text IQ marks acquisition
Columbia’s Text IQ has been bought by Relativity for an undisclosed amount.
Glō names Nanosys as buyer
Lund spinout Glō has agreed to an acquisition by Nanosys, which will now look to strengthen its market share in TV sets and enter more markets such as AR.
Snap snatches WaveOptics in $500m deal
IP Group is exiting the diffractive waveguide producer in a cash-and-share purchase by Snap.
Oatly floats on Nasdaq
The Lund research-based oat milk brand has floated in a $1.43bn IPO on the Nasdaq Global Select Market after pricing shares at $17.
Norsk Titanium nets $38m amid listing
SUNY Polytechnic University-backed Norsk Titanium has begun trading on Euronext Growth Oslo.

Editor's Picks

Otsuka takes up Veryan’s acquisition offer
ICL vascular implant spinout Veryan Medical has been bought by medical device firm Otsuka after raising $56m from investors including IP Group.
Big deal: Orchard harvests $200m IPO
Orchard Therapeutics has listed in the US following a $200m initial public offering that came just three years after the gene therapy developer was spun out of UCL.
Big deal: Novo pens $800m Ziylo acquisition
Ziylo, a spinout from University of Bristol that is working on a diabetes treatment, has been acquired by Novo Nordisk for a total that could exceed $800m.
Big deal: Nucana and Nightstar race to public markets
Nucana, a Scottish Investment Bank-backed cancer treatment developer, and Nightstar Therapeutics, an Oxford spinout focused on retinal gene therapies, have entered the public market.
test reg

Login